Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease, is an autosomal dominant neurodegenerative disorder, characterized by progressive ataxia, spasticity, and ocular movement abnormalities. The SCA3 gene, ATXN3, was identified in 1994 and contains a CAG repeat tract that increases from 12-41 to 62-84 in the disease state to produce ataxin-3 protein containing a polyglutamine (polyQ) expansion SCA3 is the most common inherited ataxia, yet a thorough understanding of the molecular basis of this disease has remained elusive. Initial studies found that ataxin-3 interacts with two proteins, HHR23A and HHR23B, that are both homologs of the DNA repair protein Rad23 Further work revealed ataxin-3 as a bona fide deubiquitinating enzyme More recently, ataxin-3 was shown to interact with the transcription factor FOXO4 as a transcriptional coactivator in the oxidative stress response Thus, while some very basic functions of ataxin-3 have been established, these advances have yielded nonintersecting lines of investigation and have not provided an underlying mechanism for SCA3 disease pathogenesis.
No takes yet. Share an insight, caveat, or question.
Ward et al. (2015) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: